Patent · US Active

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

US11242380B2 · kind B2 · utility

0Cited by

11References

11Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Wolfgang Teschner · Wien, AT
Harald Arno Butterweck · Wien, AT
Azra Pljevljakovic · Wien, AT
Theresa Friederike Bauer · Wien, AT
Bernhard Koelbl · Achau, AT
Hans-Peter Schwarz · Wien, AT
Nebojsa Nikolic · Wien, AT
Gerhard Poelsler · Wien, AT
Johanna Kindermann · Mödling, AT

Key dates

Filing date	Nov 13, 2018
Grant date	Feb 8, 2022
Priority date	—
Expiry date	Apr 22, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.